Difference between revisions of "Part:BBa K4225019"

Revision as of 12:58, 13 October 2022

Ptac-TEV-Pc-GFP-LVA-CS-IS

This is a composite part that consist of 2 composite parts, BBa_K4225008 and BBa_K4225017, and other basic parts, constitutive promoter (BBa_J23106), RBS (BBa_B0034) and a double terminator (BBa_B0015).

Contribution: HKUST 2022

Summary

The aim of this experiment is to characterise the interaction between the expression TEV protease and the subsequent cleavage of the inhibitory sequence. The inhibitory sequence (IS) is 77 amino acids from the C terminal of mRFP, placed downstream of the LVA tag sequence to shield it from being recognised and degraded from E. coli endogenous proteases ClpXP and ClpAp. TEV Protease cut site (CS) is placed in between LVA and IS, when TEV Protease is expressed, IS is cleaved off, exposing the LVA degradation tag.Thereby creating a stable GFP that can be degraded when induced.

Experiments

pTac-TEV-Pc-GFP-LVA-CS (BBa_K4225019), pTac-TEV-Pc-GFP-LVA-CS(BBa_K4225018), pTac-TEV-Pc-GFP(BBa_K4225020) and negative control (pSB1C3) is needed for the experiment.

All constructs were successfully cloned, digestion checked and sequenced. For the negative control, we obtained an empty pSB1C3 vector by linearizing a DNA that has a pSB1C3 vector with XbaI and SpeI, and re-ligating the vector back. Digestion check is done to make sure the re-ligated pSB1C3 vector is correct.

Cells carrying the constructs were inoculated overnight and back diluted to a target 0.5 OD600 (log phase period). The cultures were grown at different concentrations of IPTG for 5 h The fluorescence tracked by a plate reader at excitation wavelength of 561.0nm and emission filter of 610.0nm, absorbance is also measured. Measurements are taken at 0 and 5 hours.

Results and Discussion

Duplicate measurements are done for the experiment and standard deviation of each point is shown as an error bar in the graph. In addition, fluorescence of each data is divided by the fluorescence of the blank, which is chloramphenicol LB, in order to obtain a normalised fluorescence.

As shown in Figure 1, the last two concentration points, a decrease in fluorescence of the pTac - TEV - Pc - GFP - LVA - CS - IS construct can be observed. Which suggests that the expression of TEV can remove the shielding effect of the inhibitory sequence, thereby inducing the degradation of GFP. Moreover, the construct pTac - TEV - Pc - GFP - LVA - CS remains at a low fluorescence level, indicating that the lack of an inhibitory sequence causes the construct to be continuously degraded. These 2 observations indicate that our constructs function well. <p> <p> At low concentrations of IPTG, the fluorescence level of the test construct (pTac - TEV - Pc - GFP - LVA - CS - IS) is lower than that of the positive control (pTac - TEV - Pc - GFP).

This might be due to several reasons:

1) The inhibitory sequence did not fully shield GFP from degradation

The shielding effect of the IS is dependent on the length of the amino acid sequence and its configuration. To increase shielding effect, more amino acids can be added to the IS or a completely different IS from other proteins can be used. A comparative assay with a similar setup can be conducted to test the functionality of different IS.

2)The addition of an inhibitory sequence interfered with the folding of GFP

As the IS is sourced from 77 amino acids from the C terminal of mRFP [1] and ligated directly to the back of the pTac - TEV - Pc - GFP - LVA - CS, the secondary and tertiary protein folding of the IS may cause steric interference/ collision to GFP, decreasing its fluorescent output. Therefore, we suggest that a longer spacer sequence can be inserted between the LVA tag and IS to aid in proper protein folding.

This is a part of our engineering cycle. For more information on our engineering cycle, refer to this link

Sequence and Features